BrightGene Bio-Medical Technology Co. Ltd Financials

Market Capitalization CN¥22.31 Billion as of Jan. 1, 2026

Valuations Metrics as of Jan. 3, 2026

Trailing PE	327.07
Forward PE	83.15
Price to Sales TTM	CN¥17.59
Price to Book MRQ	CN¥8.00
Enterprise to Revenue	18.14
Enterprise to EBITDA	127.43

Financial Reports as of Jun. 30, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-06-30
Profit Margin	5.26%
Operating Margin	13.81%
Return on Assets TTM	0.62%
Return on Equity TTM	1.06%

Income Statement

Revenue TTM	CN¥1,179,975,680
Revenue per Share TTM	CN¥2.82
Quarterly Revenue Growth	5.50%
Gross Profit TTM	CN¥604,776,960
EBITDA	CN¥137,180,718
Net Income to Common TTM	CN¥62,078,204
Diluted EPS TTM	CN¥0.15
Quarterly Earnings Growth YoY	-53.30%

Balance Sheet

Total Cash MRQ	CN¥606,217,344
Total Cash per Share MRQ	CN¥1.52
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	92.46
Current Ratio MRQ	1.26
Book Value per Share MRQ	CN¥6.13

Cash Flow

Operating Cash Flow TTM	CN¥224,924,464
Levered Free Cash Flow TTM	CN¥-239,408,480

688166 Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding	422,768,244
Float Shares	245,466,695
Avg 10 Volume	5,410,544
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	39.18%
% Held by Institutions	11.70%

Stock Price Summary

Beta	0.23
Fifty Two Week Low	CN¥28.45
Fifty Two Week High	CN¥122.59
Fifty Two Week Change	38.44%
Day 50 MA	CN¥52.18
Day 200 MA	CN¥63.10

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.38
Forward Annual Dividend Yield	0.78%
Trailing Annual Dividend Rate	CN¥0.10
Trailing Annual Dividend Yield	0.20%
Payout Ratio	64.00%
Dividend Date
Ex Dividend Date	2025-06-23
Last Split Factor
Last Split Date